Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

The unbridled hype of the mid-2020s is finally colliding with the structural and infrastructure limits of 2026.

As the program engages more directly with global concerns such as the climate crisis, he will lead the way.

This language could very well describe de La Tour du Pin’s assemblages. Ultimately, her atmospheric meditation on material ...

Vitalik Buterin Unveils Ethereum Quantum-Resistance Roadmap. Vitalik Buterin has outlined a four-pronged plan to harden ...

AI-enhanced optical spectroscopy revolutionizes food quality monitoring with rapid, non-destructive analysis, ensuring safety and reducing waste in production.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Oracle-based quantum algorithms cannot use deep loops because quantum states exist only as mathematical amplitudes in Hilbert space with no physical substrate. Criticall ...

Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...